ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Dow Chemical has rejected a suggestion from billionaire investor Daniel S. Loeb to split itself into separate specialty and commodity firms. Last month, Loeb, through his hedge fund Third Point, bought a large stake in Dow and argued that Dow had little reason to keep commodity and specialty chemical operations together in one company. In a filing with the Securities & Exchange Commission, Dow says a strategic review found that “a break-up of the company in a significant manner (simplistically described as petrochemical and specialty chemical assets) created no productivity or capital allocation improvements, but rather negatively impacted Dow’s value proposition.” Third Point blasted Dow’s analysis for a lack of transparency and offered to sign a nondisclosure agreement so it could review the analysis and discuss it with Dow management.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X